Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta-analysis

Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta-analysis

Objective This study aimed to compare the efficacy and safety of different platinum adjuvant chemotherapy regimens for early-stage resected non-small-cell lung cancer (NSCLC).Design Systematic review with network meta-analysis of randomised trials.Data sources PubMed, EMBASE, The Cochrane Library, W...

Full description

Bibliographic Details
Main Authors:	Li Zhang, Wen-Feng Fang, Yi Lv, Lan-Lan Pang, Jia-Di Gan, Yi-Hua Huang, Jun Liao, Wael Abdullah-Sultan Ali
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-06-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/12/6/e057098.full

Similar Items

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
by: Xiaoyu Zhai, et al.
Published: (2017-05-01)

Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer
by: Wen-Kuan Huang, et al.
Published: (2022-08-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
by: Seiichiro Kusuhara, et al.
Published: (2021-05-01)

Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
by: Zuo Fei, et al.
Published: (2019-04-01)

DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
by: Zhiyuan Fan, et al.
Published: (2023-01-01)

Comparison of two platinum-containing chemotherapy regimens in the treatment of advanced cervical cancer with concurrent chemoradiotherapy
by: Ya-Yi Chen, et al.
Published: (2024-12-01)

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC
by: Brazel D, et al.
Published: (2022-05-01)

Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib
by: Zhang SS, et al.
Published: (2022-04-01)

Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis
by: Chih-Chieh Yen, et al.
Published: (2021-07-01)

Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chemotherapy: A multicenter retrospective study
by: Kakeru Hisakane, et al.
Published: (2023-07-01)

Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis
by: Kiichi Sugimoto, et al.
Published: (2021-04-01)

Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report
by: Naoki Aomatsu, et al.
Published: (2020-04-01)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
by: Yuji Miyamoto, et al.
Published: (2020-11-01)

Correction to: Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis
by: Kiichi Sugimoto, et al.
Published: (2021-04-01)

Survival Analysis of Ovarian Carcinosarcomas Depending on Platinum or Doxorubicin Based Adjuvant Chemotherapy
by: İlker Selçuk, et al.
Published: (2015-04-01)

Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer
by: Vanita Noronha, et al.
Published: (2012-01-01)

Evolution of Adjuvant Chemotherapy and Efficacy of Commonly Used Regimens in Colorectal Cancer
by: S.M. Adiga, et al.
Published: (2012-04-01)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
by: Po-Huang Chen, et al.
Published: (2022-12-01)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.
by: Young Shin Chung, et al.
Published: (2017-01-01)

Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.
by: Chongqing Tan, et al.
Published: (2013-01-01)

Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer
by: Tsuyoshi Shinohara, et al.
Published: (2013-01-01)

Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung
by: Shih‐Hsin Hsiao, et al.
Published: (2022-05-01)

P002 Adjuvant chemotherapy for resected early-stage triple negative breast cancer
by: C. Solinas, et al.
Published: (2023-03-01)

Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
by: Sandra Wallerek, et al.
Published: (2015-06-01)

Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
by: Yanxin Sun, et al.
Published: (2024-08-01)

VATS lobectomy facilitates delivery of adjuvant chemotherapy following NSCLC resection
by: Abah, U, et al.
Published: (2012)

Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection
by: Xiao‐hui Li, et al.
Published: (2023-12-01)

Surgical resection of orbital primitive neuroectodermal tumor without adjuvant chemotherapy
by: Faizan Mehmood, et al.
Published: (2022-01-01)

Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy
by: Richard Fischer, et al.
Published: (2012-01-01)

Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer
by: Yu Kyung Lee BA, et al.
Published: (2018-09-01)

Influence of Programmed Death Ligand-1-Gene Polymorphism rs822336 on the Prognosis and Safety of Postoperative Patients with NSCLC Who Received Platinum-Based Adjuvant Chemotherapy
by: Zhao M, et al.
Published: (2020-08-01)

Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
by: Xiuqiong Chen, et al.
Published: (2021-03-01)

Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
by: Bin Qiu, et al.
Published: (2021-11-01)

Cost‐Effectiveness Analysis of Adjuvant Alectinib versus Platinum‐Based Chemotherapy in Resected ALK‐Positive Non‐Small‐Cell Lung Cancer in the Chinese Health Care System
by: Qiran Wei, et al.
Published: (2024-11-01)

Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy
by: Ping Chen, et al.
Published: (2022-09-01)

Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study
by: Yan Xu, et al.
Published: (2021-07-01)

Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
by: Qing Tao, et al.
Published: (2020-04-01)

Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
by: Zi-Qing Shen, et al.
Published: (2024-01-01)